Celgene (CELG)

Company Description

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.

 

COMPANY ADDRESS
86 Morris Avenue
Summit, NJ 07901
United States

COMPANY PHONE
908-673-9000

COMPANY WEBSITE



Get BioInvest's perspective on Celgene's CEO


Latest Company News

3 Biotech Stocks to Buy Right Now Schaeffers Research (blog) - 4 hours ago ... next month, as well as the 25 best stocks to own during the dog days of summer, including healthcare stocks Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Regeneron Pharmaceuticals Inc (NASDAQ:REGN), and Celgene Corporation (NASDAQ:CELG). Health Care Select Sector SPDR Fund Experiences Big Inflow - Nasdaq [...]
Tue, Jun 27, 2017 5:37:00 PM, Continue reading at the source
Agios/Celgene's Leukemia Candidate Positive in Phase I/II Zacks.com - 7 hours ago We remind investors that IDHIFA is being jointly developed by Agios in collaboration with Celgene Corporation (CELG - Free Report) . [...]
Tue, Jun 27, 2017 2:41:00 PM, Continue reading at the source
Celgene Corporation (CELG) is down on its 52-week high NY Stock News - 10 hours ago The technicals for Celgene Corporation (CELG) has spoken via its technical chart and the message is loud and clear. Based on that message, this is the relevant information necessary to make sense of that current setup. [...]
Tue, Jun 27, 2017 12:22:00 PM, Continue reading at the source
Why Investors remained confident on First Solar, Inc. (FSLR), Celgene ... StockNewsJournal - Jun 26, 2017 Celgene Corporation (NASDAQ:CELG), at its latest closing price of $134.31, it has a price-to-book ratio of 13.66, compared to an industry average at 19.95. How much upside really exists in First Solar, Inc. (FSLR) and Celgene ... - USA Commerce Daily [...]
Mon, Jun 26, 2017 6:11:00 PM, Continue reading at the source
Celgene Corporation Risk Points versus Health Care CML News - Jun 23, 2017 This is a scatter plot analysis of the critical risk points from the option market for Celgene Corporation (NASDAQ:CELG) compared to its own past and the Health Care ETF. [...]
Fri, Jun 23, 2017 10:07:00 PM, Continue reading at the source
Celgene: I Don't Necessarily Understand The Science, But I Love The Numbers Seeking Alpha - Jun 22, 2017 "Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. [...]
Thu, Jun 22, 2017 6:33:00 PM, Continue reading at the source
Can Celgene Corporation Be a Value Stock? Motley Fool - Jun 15, 2017 Call me crazy, but I don't think Celgene Corporation (NASDAQ:CELG) is quite as expensive as it looks on the surface. Sure, the biotech stock is trading at a price-to-earnings multiple nearly twice that of the average stock in the benchmark S&P 500 ... Celgene (CELG) Reports Data on Lupus Drug in Phase II Trial - Yahoo Finance Today Analysts Focus on Fossil Group, Inc. (FOSL), Celgene Corporation (CELG) - StockNewsJournal [...]
Thu, Jun 15, 2017 1:07:00 PM, Continue reading at the source
bluebird bio and Celgene Corporation Announce Updated Clinical Results from ... Business Wire (press release) - Jun 5, 2017 CAMBRIDGE, Mass. & SUMMIT, N.J.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ:BLUE), and Celgene Corporation (NASDAQ:CELG) today announced that updated results from the ongoing CRB-401 Phase 1 clinical study of bb2121, an investigational ... [...]
Mon, Jun 05, 2017 11:30:00 AM, Continue reading at the source
Celgene Defends The Stock With Positive Portents Seeking Alpha - Jun 1, 2017 The CEO of CELG presented comments and did a Q&A at a healthcare conference Wednesday. He broke several bits of news, including on the pace of business in Q2 and on a key pipeline drug, ozanimod. [...]
Thu, Jun 01, 2017 9:45:00 PM, Continue reading at the source
IMIDomics SL and Celgene Corporation Enter into Strategic Collaboration to ... Business Wire (press release) - May 31, 2017 BARCELONA, Spain--(BUSINESS WIRE)--IMIDomics SL announced today they have entered into a strategic collaboration with Celgene Corporation, to advance the discovery and development of novel treatments to address patients with Immune-Mediated ... [...]
Wed, May 31, 2017 12:00:00 PM, Continue reading at the source